PDE10A and obesity due to melanocortin 4 receptor deficiency: Besides the complex role of PDE10A in the pathophysiology of several brain disorders discussed above, there is strong evidence that PDE10A is involved in the regulation of whole body energy balance and thus, selective PDE10A inhibitors are proposed as novel therapeutics for the treatment of obesity [1,172,173].